Lv12
40 积分 2026-07-20 加入
Long-Term Outcomes and Immune Reconstitution Following CD7 CAR-T Bridged Allogeneic HSCT In Refractory/Relapsed T-ALL/Lbl: A Comparative cohort study
21小时前
待确认
Autologous Nanobody-Derived Fratricide-Resistant CD7-CAR T-cell Therapy for Patients with Relapsed and Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma
22小时前
已完结
皖公网安备34019202002308
